Table 2.
Baseline demographic and clinical characteristics in individuals with progressive glycemic impairment compared to no change at 2.5 years
| Characteristics Mean ± SD, Median (IQR), or n (%) | Progressive Glycemic Impairment (n = 23) | No Change (n = 71) | p-value |
|---|---|---|---|
| Sex (male) | 14 (61) | 41 (58) | 0.070 |
| Age (years) | 55 ± 9 | 57 ± 9 | 0.310 |
| Current Smoking | 8 (9) | 3 (4) | 0.705 |
| Physical Activity (MET-minutes/week) | 1260 (473, 2100) | 1470 (613, 2940) | 0.293 |
| Systolic Blood Pressure (mm Hg) | 119 ± 20 | 122 ± 17 | 0.420 |
| Diastolic Blood Pressure (mm Hg) | 71 ± 13 | 71 ± 10 | 0.942 |
| Total Cholesterol (mg/dL) | 188 ± 39 | 188 ± 29 | 0.955 |
| LDL-c (mg/dL) | 113 ± 33 | 112 ± 27 | 0.872 |
| HDL-c (md/dL) | 51 ± 16 | 50 ± 14 | 0.780 |
| Triglycerides (mg/dL) | 120 ± 65 | 126 ± 56 | 0.676 |
| Fasting Blood Glucose (mg/dL) | 91 ± 8 | 91 ± 11 | 0.813 |
| Insulin (μIU/mL) | 11.5 ± 6.2 | 11.5 ± 6.2 | 0.807 |
| HOMA-IR (μIU/mL*mmol/L) | 2.6 ± 1.5 | 2.8 ± 2.1 | 0.715 |
| Body Mass Index (kg/m2) | 25.7 ± 4.7 | 25.9 ± 4.5 | 0.878 |
| Waist Circumference (cm) | 93 ± 12 | 94 ± 12 | 0.856 |
cm centimeters, HDL-c high density lipoprotein cholesterol, HOMA-IR homeostasis model assessment-insulin resistance, kg/m 2 kg per meter2, LDL-c low density lipoprotein cholesterol, mcU/mL microUnit per milliliter, mg/dL milligrams per deciliter, mm Hg millimeters of mercury, SD standard deviation